Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Date:7/29/2009

t income calculation Reported GAAP net income $53.0 $60.3 $102.1 $110.9 Adjusted for: Global supply chain initiative(1) 8.6 5.4 17.8 19.1 Acquisition and licensing charges 11.9 0.5 11.9 5.5 Loss (gain) on securities - - 1.1 (1.4) Loss (gain) on asset sales 0.2 - (1.3) - Loss on early extinguishment of debt - - - 1.1 Legal settlements - (15.0) 18.8 (15.0) Income taxes (3.3) 3.4 (13.5) (3.6) ---- ---- ----- ----- Adjusted net income 70.4 54.6 136.9 116.6 Add: Interest expense on CODES, net of tax 2.0 1.9 3.9 3.9 --- --- --- --- Adjusted net income, adjusted for interest on CODES $72.4 $56.5 $140.8 $120.5 ===== ===== ====== ====== Diluted earnings per share Diluted earnings per share - GAAP $0.46 $0.53 $0.89 $0.98 ===== ===== ===== ===== Diluted earnings per share - Adjusted $0.61 $0.48 $1.19 $1.03 ===== ===== ===== ===== Basic weighted average common shares outstanding 103.4 102.7 103.2 102.7 Effect of dilutive securities: Conversion of CODES 14.4 14.4 14.4 14.4 Dilutive share-base
'/>"/>
SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... , ... “My mother and husband use oxygen therapy and the tubing irritates ... could be a comfortable way to prevent the irritation, so I invented this.” She ... more secure way to anchor the cannula tubing used in oxygen therapy and it ...
(Date:8/31/2015)... ... August 31, 2015 , ... A year ago this month, Seniors Guide ... release a new issue commemorating the successful first year. , “We started the ... potentially difficult time in their lives,” says Melissa Wolfert, founding Publisher for Seniors Guide ...
(Date:8/31/2015)... ... ... There’s big news for ZendyHealth , a Los Angeles-based startup company ... health plans (CDHPs) are a growing phenomenon, and ZendyHealth has brought on two experts ... another to answer customers’ questions directly. , John Young, CEO of Consumerdriven, LLC will ...
(Date:8/31/2015)... Georgia (PRWEB) , ... August 31, 2015 , ... ... the Eco Commerce Exchange and Organization Supporting Business Owners and provided a tour ... in Atlanta, Georgia, represents the success possible to international companies expanding business in ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, July 11, 2015, ... Center in New York City, NYSATA was proud to recognize Dr. Merritt F. Spear ... Scriber Recognition Award, named after long-time NYSATA member and Ithaca College athletic trainer ...
Breaking Medicine News(10 mins):Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 2Health News:Seniors Guide Magazine Celebrates Its First Year in Columbus With A Special Anniversary Issue 3Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:PartnerTech Supports Economic Growth as Host 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 2Health News:NYS Athletic Trainers' Association Presents Recognition Awards at Annual Conference 3
... ... ... ... ...
... -- (March 5, 2010) Components of the blood or ... single stem cell that gives rise to all the different ... of Medicine ( www.bcm.edu ) in a report that appears ... Cell ( www.cell.com/cell-stem-cell/ ) "While previous ...
... Cholangiocarcinoma (CCA), a bile duct cancer, is one of ... difficult to diagnose and has high metastatic and mortality ... receptor, has frequently been found in CCA and is ... activation induces a variety of cellular processes, including cell ...
... Calculus Bovis compound preparation (ICCBco) in the treatment ... schistosomiasis as the experimental animal model, a research ... trial to observe pathological changes and pathological effect ... the lung tissue of portal hypertensive rabbits with ...
... ... to let tax season negatively affect their personal credit report , ... Delray Beach, FL (PRWEB) March 4, 2010 -- NationalCreditReport.com, ... help consumers improve their credit scores. Although the tax filing deadline is drawing near, there ...
... appears to combat mesothelioma tumors , THURSDAY, March 4 ... cancer mesothelioma is safe, according to a new study. ... which infuses a patient,s own dendritic cells with antigen ... found that it induced an immune T-cell response against ...
Cached Medicine News:Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 2Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 3Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 4Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 5Health News:Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus 6Health News:Theory of single stem cell for blood components challenged 2Health News:Different signaling pathways of cholangiocarcinoma 2Health News:Treatment of portal hypertensive pulmonary lesions induced by schistosomiasis 2Health News:NationalCreditReport.com Offers Simple Tax Saving Tips That Can Improve Credit Scores 2Health News:NationalCreditReport.com Offers Simple Tax Saving Tips That Can Improve Credit Scores 3Health News:Vaccine for Asbestos-Related Cancer Looks Safe 2
(Date:8/29/2015)... y LONDRES, August 29, 2015 ... para los sistemas de imagen por Ultrasonidos ... Ecografía, tiempos de examen rápidos y un flujo de ... confianza diagnóstica en el proceso de detección de Cardiopatías ... PHIA) ha anunciado hoy el lanzamiento europeo de ...
(Date:8/28/2015)... According to a new market ... Prostate) Type (Protein & Genetic Biomarkers) Profiling Technology (Proteomics, ... Geography - Global Forecast to 2020", published by MarketsandMarkets, ... 17,689.0 Million USD by 2020 at a CAGR of ... Browse 191 Tables and 38 F ...
(Date:8/28/2015)... , Aug. 28, 2015 ... the addition of the "Investigation Report on China,s ... Tobramycin is a traditional antibiotic whose eye drop ... the treatment of potential infection or inflammation caused by ... China are able to produce tobramycin, among ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5Investigation Report on China's Tobramycin Market, 2015-2019 2
... NEW YORK, Sept. 27 Keryx Biopharmaceuticals, Inc. (Nasdaq: ... Chief Executive Officer, will be presenting at the JMP Securities ... in New York City.  Mr. Bentsur,s presentation is scheduled to ... A live audio webcast of Mr. Bentsur,s presentation ...
... Mass., Sept. 25 Boston Scientific Corporation (NYSE: ... data from the HORIZONS-AMI trial.  The trial, sponsored ... support from Boston Scientific and The Medicines Company ... determine the safety and efficacy of the TAXUS® ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at JMP Securities Healthcare Conference 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 2HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 3HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: